The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports the company has $17.28 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $17.28 B | 11.99% |
2021-12-31 | $15.43 B | 17.86% |
2020-12-31 | $13.09 B | -260.27% |
2019-12-31 | $-8.18 B | -3.24% |
2018-12-31 | $-8.45 B | -265.71% |
2017-12-31 | $5.09 B | 9.94% |
2016-12-31 | $4.63 B | 17.52% |
2015-12-31 | $3.94 B | 126.46% |
2014-12-31 | $1.74 B | -61.22% |
2013-12-31 | $4.49 B | 33.57% |
2012-12-31 | $3.36 B | -72.49% |
2011-12-31 | $12.22 B | -22.16% |
2010-12-31 | $15.70 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $95.91 B | 454.84% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $11.29 B | -34.66% | ๐บ๐ธ USA |
![]() Amgen AMGN | $5.34 B | -69.06% | ๐บ๐ธ USA |
![]() Biogen BIIB | $13.78 B | -20.25% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $20.93 B | 21.13% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $31.88 B | 84.45% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $35.81 B | 107.16% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $14.01 B | -18.94% | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | $1.68 B | -90.26% | ๐บ๐ธ USA |